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ABSTRACT
Mammalian Musashi1 (Msi1) is an RNA-binding
protein that regulates the translation of target
mRNAs, and participates in the maintenance of
cell ‘stemness’ and tumorigenesis. Msi1 reportedly
binds to the 30-untranslated region of mRNA of
Numb, which encodes Notch inhibitor, and
impedes initiation of its translation by competing
with eIF4G for PABP binding, resulting in triggering
of Notch signaling. Here, the mechanism by which
Msi1 recognizes the target RNA sequence using its
Ribonucleoprotein (RNP)-type RNA-binding
domains (RBDs), RBD1 and RBD2 has been
revealed on identification of the minimal binding
RNA for each RBD and determination of the
three-dimensional structure of the RBD1:RNA
complex. Unique interactions were found for the
recognition of the target sequence by Msi1 RBD1:
adenine is sandwiched by two phenylalanines and
guanine is stacked on the tryptophan in the loop
between b1 and a1. The minimal recognition se-
quences that we have defined for Msi1 RBD1 and
RBD2 have actually been found in many Msi1
target mRNAs reported to date. The present study
provides molecular clues for understanding the
biology involving Musashi family proteins.
INTRODUCTION
The Musashi (Msi) family comprises a group of RNA-
binding proteins that function as translational regulators
of target mRNAs and that play critical roles in stem cell
maintenance and self-renewal capability (1,2). Msi and
Msi-like proteins have been discovered in various multicel-
lular animals, such as Drosophila (3), Caenorhabditis
elegans (4), newt (5), mouse (6,7) and human (8)
(64 genes in the NCBI database, Feb 2010). In mammals,
two members, Msi1 and Msi2 have been identiﬁed to date
(2,6,7). Both mouse Msi1 and Msi2 have two tandemly
connected ribonucleoprotein-type RNA-binding domains
(RBDs), also known as RRMs (RNA recognition motifs),
RBD1 and RBD2, in its N-terminal region, which are
followed by a putative PABP [poly(A)-binding protein]
binding region (9). Mouse Msi1 and Msi2 consist of 362
and 346 amino acid residues, respectively. Their sequence
identity is 69%, whereas that of the region containing the
two RBDs (20–191 in Msi1 and 21–192 in Msi2) is 86%.
RBDs are one of the families of well-known single-
stranded polynucleotide binding domains that have a
b1a1b2b3a2b4 topology, forming a four-stranded
anti-parallel b sheet packed against two a-helices (10,11).
In the b-sheet, there are two highly conserved sequence
stretches, RNP1 (in the b3 strand) and RNP2 (in the b1
strand). Many of the so-called classical RBDs contain
three aromatic amino acid residues in RNP1 and RNP2
that play important roles in nucleic acid recognition. We
previously determined the structures of RBD1 and RBD2
of mouse Msi1, and showed that each RBD has three
solvent-exposed phenylalanines in RNP1 and RNP2
(12,13). Subsequent RNA binding and molecular
dynamics studies involving nuclear magnetic resonance
(NMR) have revealed that these phenylalanines are im-
portant for direct RNA binding (12,13). Substitution of
these phenylalanines of RBD1 with alanines results in loss
of translational repression and the RNA-binding activity
of Msi1 (14), which is consistent with the results of our
NMR experiments.
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identiﬁed as (G/A)UnAGU (n=1–3) by means of an
in vitro selection method (14). Five target mRNAs con-
taining this sequence in their 30-UTRs have been identiﬁed
and studied: numb (14), p21
WAF 1 (15), c-mos (16) and
doublecortin (dcx) (17) and Adenomatous Polyposis Coli
(APC) (18). Activation of the Notch signaling pathway
positively regulates the self-renewal of various stem cells
including neural stem cells (19,20) and cancer develop-
ment (21). The numb mRNA encodes a protein that
suppresses the Notch signaling pathway, whereby Numb
promotes the differentiation of neural stem cells (NSCs).
Msi1 has been proposed to bind to the 30-UTR of numb
mRNA, and then to compete with translation initiation
factor eIF4G for PABP binding (9). This will lead to
translational repression of numb mRNA, thereby main-
taining the stem cell state. The Wnt signaling pathway
plays an important role in the maintenance of
pluripotency, as well as in the process of somatic cell
reprogramming (22). p21
WAF 1 mRNA encodes a
cyclin-dependent kinase inhibitor, which negatively regu-
lates Wnt gene expression (23). Msi1 binds to the 30-UTR
of p21
WAF 1 mRNA and represses its translation. This
results in upregulation of the cell cycle via the Wnt signal-
ing pathway, whereby cell proliferation and multipotency
are maintained (15). dcx mRNA, which encodes a protein
that is related to the migration of newborn neurons and
neural development (24,25), was identiﬁed as another
target of Msi1 by means of an in vitro virus (IVV)
method (17). The Msi1 binding sequence was again
found in the 30-UTR of dcx mRNA. Recently, more
genes have been shown to contain Msi1 binding sequences
(26). Collectively, the products of these genes of Msi1
targets were shown to be involved in cell cycle regulation,
cell proliferation, self-renewal and apoptosis.
Strong expression of Msi1 has also been observed in
proliferative cell populations in tumor tissues, such as
medulloblastomas (27,28), gliomas (29,30), astrocytomas
(31), retinoblastomas (32) and colorectal adenomas (33).
Recent reports indicate that a causal role of elevated Msi2
expression in the progression of chronic myeloid leukemia
(CML) from a slow growing chronic form to an aggressive
blast crisis form through the translational suppression of
numb mRNA and subsequent activation of Notch
pathway (34–36). These reports emphasize the importance
of examining the cooperation and division of roles of Msi1
and Msi2 proteins to fully understand the physiological
functions of the Msi family and its relation with diseases.
Another line of evidence suggested that Msi1 can inﬂu-
ence stem cell maintenance and differentiation by
controlling the subcellular localization of proteins
involved in miRNA biogenesis, as well as by regulating
the translation of its target mRNA. It was shown that
Msi1 acts in concert with Lin28to regulate post-
transcriptional microRNA (miRNA) biogenesis in the
cropping step, which occurs in the nucleus (37).
As mentioned above, our knowledge about the target
mRNAs and regulatory pathways of Msi family members
is increasing. To obtain a clear understanding of the mech-
anism of action in translational repression and other
obscure functions, and of the speciﬁcity determinants of
their RBDs, we have undertaken NMR-based binding and
structural studies on the two RBDs from Msi1. NMR
titration experiments involving 6-nt RNA oligomers
derived from the target sequence revealed the binding
properties of RBD1 and RBD2. The consensus se-
quences for the binding of RBD1 and RBD2
were identiﬁed as r(GUAG) and r(UAG), respectively.
The three-dimensional solution structure of Msi1
RBD1:r(GUAGU) revealed the characteristics of the
interactions. The adenine and guanine residues at the
third and fourth positions of r(GUAG) are stacked on
the conserved F23 and F65 in the RNP2- and
RNP1-sequences, respectively. Interestingly, the third
adenine is sandwiched by another phenylalanine, F96,
which resides immediately after the 4th b-strand. In
addition, the ﬁrst guanine residue stacks onto W29 in
the loop between b1 and a1. These stacking interactions
are unique to the recognition of its target RNA by Msi1
RBD1. F96 and W29 turned out to be limited to, but
conserved among, members of the Msi protein family
(Msi1 and Msi2). Thus, the structure we have deﬁned
shows the mechanism underlying the architecture of
RNA recognition by Msi1 RBD1. Msi1 RBD2 partly
contains the same recognition platform as that in Msi1
RBD1. This architecture is highly conserved among Msi
proteins. Thus, this study provides a molecular basis for
rationally predicting the interaction of each member of the
Msi protein family with its de novo target RNA sequence.
MATERIALS AND METHODS
Preparation of Msi1 and RNA
DNA encoding RBD1 and RBD2 of Msi1 (residues
20–103 and 109–191, respectively) was ampliﬁed by
polymerase chain reaction (PCR) from the mouse Msi1
gene by the conventional polymerase chain reaction, and
then subcloned into pET15b (Novagene). The proteins
were expressed with an extra His6-tail and a thrombin
cleavage site at the N-terminus in Escherichia coli,
BL21(DE3) pLysS, at 37 C in minimal medium (M9) con-
taining 1g/l [
15N] ammonium chloride, 3g/l [
13C] glucose
(for
15N and
13C-labeled proteins), vitamins, mono-
nucleotides, metals, 100mg/l carbenicillin and 34mg/l
chloramphenicol (38). Cells were grown to OD600 0.5
and induced with 1mM iso-propylthio-b-D-galacto-
pyranoside (IPTG). Cells were harvested after 4h by cen-
trifugation. Cell pellets were resuspended in lysis buffer
[1 M NaCl, 10mM benzamidine, 1mM PMSF, 50mM
Tris–HCl (pH 8.0)], disrupted by mild sonication and
then centrifuged at 20000g. The soluble fraction contain-
ing the fusion protein was puriﬁed by Ni
2+-afﬁnity chro-
matography (Hi-Trap chelating HP column, GE
Healthcare). The purest fractions were pooled and
dialyzed against 20mM Tris–HCl buffer (pH 7.5) contain-
ing 5mM DTT and 1 M NaCl (MWCO 3000) in order to
remove RNA impurities, and then further dialyzed against
the same solution but containing no NaCl. The dialyzed
protein solution was loaded onto the cation exchange
column (HiTrap SP HP column, GE Healthcare) and
further puriﬁed. The puriﬁed protein was dialyzed
Nucleic Acids Research,2012, Vol.40, No. 7 3219against NMR buffer [5 mM DTT, 20mM MES (pH 6.0)]
and concentrated by ultraﬁltration [Amicon Ultra
(MWCO 3500), Millipore]. The concentrations of the
Msi1 RBD1 and RBD2 solutions were determined by
ultraviolet (UV) spectroscopy. No detectable impurities
were found on 15% polyacrylamide gel electrophoresis
(PAGE) analysis. RNA oligomers (Table 1) were
purchased from Hokkaido System Science Inc.
NMR spectroscopy
NMR spectra were recorded at 298K on Bruker Avance
600, Avance 800 and Avance II 900 spectrometers, all of
which are equipped with a triple resonance (
1H/
13C/
15N)
cryoprobe. Data were processed with NMRPipe (39), and
analyzed with Kujira (40) and Sparky (http://www.cgl
.ucsf.edu/home/sparky).
NMR titration experiments on Msi1 RBD1 or RBD2
with a series of RNA oligomers: r(UAGGUAGUAGUU
UUA) (numb12), r(UAGGUA) (numb6-1), r(GGUAGU)
(numb6-2), r(UAGUAG) (numb6-3), r(GUAGUU)
(numb6-4), r(AGUUUU) (numb6-5), r(GUUUUA)
(numb6-6) and r(GUAGU) (numb5) were performed by
recording
1H-
15N HSQC spectra at 298K. Increasing
amounts of the unlabeled RNA oligomers were added to
50mM
15N-labeled proteins, to obtain molar ratios of 1:0,
1:0.1, 1:0.2, 1:0.5, 1:0.7, 1:1.0, and 1:1.2.
NMR spectra of the Msi1:numb5 complex were
recorded using a sample comprising 300mM
13C,
15N-labeled Msi1 protein and 300mM unlabeled numb5
dissolved in the NMR buffer containing 95% H2O/5%
D2O.
15N and
13C resonances of the protein portion
were assigned by standard double and triple resonance
NMR experiments (41–43). Sequence-speciﬁc backbone
assignment of Msi1 RBD1 (Ca,C b,C 0, N, HN) was
made based on HNCO, HNCA, HN(CA)CO,
HN(CO)CA, CBCA(CO)NH and HNCACB. The side
chains of Msi1 RBD1 were assigned based on
HBHA(CO)NH, HC(CCO)NH, C(CCO)NH, H(C)CH-
TOCSY, H(C)CH-COSY, CCH-TOCSY, CCH-COSY,
1H-
13C NOESY-HSQC and
1H-
15N NOESY-HSQC (80
and 200ms mixing times). RNA assignments were made
based on
13C,
15N-[f1,f2]-ﬁltered NOESY (200ms mixing
times),
13C,
15N-[f2]-ﬁltered TOCSY (43ms mixing time)
and DQF-COSY. Inter-molecular nuclear Overhauser
effects (NOEs) were recorded using
1H-
13C
NOESY-HSQC,
1H-
15N NOESY-HSQC (80 and 200ms
mixing times), and
13C,
15N-[f2]-ﬁltered NOESY (150 and
200ms mixing times). The assignments are deposited in
the BMRB data bank under accession number 150218.
Structure calculation
The 3D structure of the Msi1 RBD1:r(GUAGU) (numb5)
complex was determined by combining the automated
NOESY cross-peak assignments and the structure calcu-
lations with torsion angle dynamics implemented in the
program CYANA 2.1. Protein backbone f, c torsion
angle restraints were determined by chemical shift
database analysis, using the program TALOS (44).
Restraints for the  
1dihedral angles were obtained by
analyzing the pattern of inter- and intra-residual nuclear
overhauser effect (NOE) intensities (45). Automatic as-
signment of the intra-protein NOEs of RBD1 in
complex with numb5 was carried out with CYANA. The
inter-molecular protein–RNA inter-molecular and
intra-RNA NOEs were manually assigned, using 2D
ﬁltered-NOESY spectra. Protein–RNA inter-molecular
and intra-RNA NOEs from the 2D ﬁltered-NOESY
spectrum with a mixing time of 80ms were divided into
two groups with upper distance bounds of 3.5 and 5.0A ˚ ,
respectively according to their intensities. The upper
distance bound of 5.5A ˚ was applied for the
inter-molecular NOEs that could only be identiﬁed from
the 2D ﬁltered-NOESY spectrum with a mixing time of
150ms. In total, 58 inter-molecular NOEs between Msi1
RBD1 and numb5 were used for the structure calcula-
tions. RNA sugar puckering of Gua1, Ura2, Ade3 and
Gua4 was determined from TOCSY and DQF-COSY
spectra (46). All the RNA   torsion angles were
determined from the intra-residual NOE intensities (46).
The structure calculations started from 200 randomized
conformers and involved the standard CYANA simulated
annealing schedule, with 40000 torsion angle dynamics
steps per conformer. The 40 conformers with the lowest
ﬁnal CYANA target function values were further reﬁned
with the AMBER9 program, using an AMBER 2003 force
ﬁeld and a generalized Born solvation model, as described
previously (47). The 20 conformers that were most consist-
ent with the experimental restraints were selected as ﬁnal
structures. PROCHECK-NMR (48) and MOLMOL (49)
were used to validate and to visualize the ﬁnal structures,
respectively. The coordinates for the ensembles of the 20
conformers of the Msi1 RBD1 in its numb5 bound form
was deposited in the RCSB Protein Data Bank.
RESULTS
RNA binding of two connected RBDs, RBD1–2, may
cause multiple registration
The signals in the
1H-
15N HSQC spectrum for each indi-
vidual [
15N]-labeled RBD were dispersed and exhibited
uniform peak intensities, which are characteristics of a
well-folded polypeptide. We previously determined the
structure of individual RBD1 and RBD2 in their free
states (12,13). A protein construct containing the two
RBDs (RBD1–2, 20–191) also gave well-resolved
1H-
15N
HSQC spectra in the free state (Supplementary Figure S1).
The spectrum of RBD1-2 turned out to be almost the
Table 1. RNA sequences used for the NMR titration experiments in
this study
RNA oligomer Sequence
numb15 UAGGUAGUAGUUUUA
numb6-1 UAGGUA
numb6-2 GGUAGU
numb6-3 UAGUAG
numb6-4 GUAGUU
numb6-5 AGUUUU
numb6-6 GUUUUA
numb5 GUAGU
3220 Nucleic Acids Research, 2012,Vol.40, No. 7summation of the spectra of both RBDs. Some differences
are found for the signals that are assigned to the linker
region that connects the two RBDs. This linker region
does not exist in the individual RBD constructs. These
observations indicate that there is no inter-domain inter-
action between RBD1 and RBD2. This was also sup-
ported by paramagnetic relaxation enhancement (PRE)
experiments. PRE is a technique that provides longer
distance information ( 15A ˚ ) than commonly used
nuclear Overhauser effect spectroscopy (NOESY) ( 5A ˚ )
(50). PRE experiments were carried out to obtain the
inter-domain distances between RBD1 and RBD2 within
the RBD1–2. Msi1 RBD1–2 V118C mutant, which was
spin-labeled with (1-oxyl-2,2,5,5-tetramethylpyrroline-
3-methyl)-methanethiosulfonate (MTSL) at C118 in
RBD2 (C118 locates in the loop between b1 and a1) was
used. No inter-domain PREs, however, were observed.
This indicates that the two domains within RBD1–2 are
not arranged in any particular orientation or they are
apart in the free state (Supplementary Figure S2). We
then titrated the target RNA, r(UAGGUAGUAGUUU
UA) [numb15; (14)], against RBD1–2 and monitored the
signal perturbations in the
1H-
15N HSQC spectra. First,
the sample solution became turbid when the molar ratio
reached [RBD1-2]:[numb15] 1.0:0.5. Under these condi-
tions, the signals were signiﬁcantly line-broadened. As in
the titration experiments, we have noticed that in the
range of [RBD1–2]:[numb15]=1.0:0.5 to 1.0:2.0, the
chemical shifts of most of the signals changed linearly in
one direction. However, some signals started to change in
different directions when the molar ratio exceeded
[RBD1-2]:[numb15] 1.0:1.0 (Supplementary Figure S1).
The origin of this behavior is not clear. We suppose that it
could be due to multiple registration of numb15 onto
RBD1-2, that may cause the formation of oligomerized
complexes under the present NMR conditions. An alter-
native possibility is that an initial encounter complex is
formed in the initial phase, followed by the formation of
some more speciﬁc complex later on.
Identiﬁcation of the consensus RNA sequences for the
binding of Msi1 RBD1 and RBD2
To avoid analysis of such inhomogeneous samples, we
made protein constructs, each of which contained only
the RBD1 or RBD2 portion of Msi1, and to identify
the RNA sequences that bind to RBD1 and
RBD2, we prepared six 6-nt RNA oligomers: r(UAG
GUA) (numb6-1), r(GGUAGU) (numb6-2), r(UA
GUAG) (numb6-3), r(GUAGUU) (numb6-4), r(AGUU
UU) (numb6-5) and r(GUUUUA) (numb6-6), all of
which were derived from r(UAGGUAGUAGUUUUA)
(numb15), as described in Table 1. NMR titration experi-
ments were then performed on each of the
15N-labeled
RBDs (50mM), a series of 2D
1H 
15N HSQC spectra
being measured with the addition of each of the RNA
oligomers. All 6-nt RNA oligomers had an extensive
effect on the
1H-
15N HSQC spectra upon titration.
These changes reached a plateau when an equimolar
quantity of RNA was added to the RBDs (Figure 1).
This indicates that both RBD1 and RBD2 interact with
each of the RNA oligomers in a 1:1 stoichiometric
manner. It should be noted that the binding of RBD1
with numb6-2 or numb6-4 (Figure 1B and D), and that
of RBD2 with numb6-1, numb6-2 or numb6-4 (Figure 1G,
H and J) exhibited slow exchange on the NMR timescale,
while the other pairs exhibited either fast (RBD1:
Figure 1E and F; RBD2: Figure 1K and L) or intermedi-
ate exchange (RBD1: Figure 1A and C; RBD2: Figure 1I).
In general, the binding of two molecules exhibiting slow
exchange on the NMR time scale is considered to be
higher afﬁnity than the binding of two molecules
showing either fast or intermediate exchange. Thus,
these results indicate that RBD1 binds to numb6-2 and
numb6-4 with higher afﬁnity than to the other four RNA
oligomers. Figure 1M presents the chemical shift changes
of the HN signals of the Msi1 RBD1 residues upon the
addition of each of the RNA oligomers in a 1:1 molar
ratio. In this ﬁgure, the values for the chemical shift
changes upon the addition of numb6-2 and numb6-4
superimpose very well on those of all the residues of
Msi1 RBD1.
A series of 6-nt RNA titration experiments indicated
that Msi1 RBD1 binds r(GUAGU)-containing RNA
oligomers with high afﬁnity. In order to determine the
effect of the extra guanine on the 50 side of numb6-2
and uracil on the 30 side of numb6-4 on the afﬁnity, we
performed an experiment on competition between
numb6-2 and numb6-4 in RBD1 binding by means of
chemical shift perturbation. The addition of numb6-2
(12.5nmol) and numb6-4 (12.5nmol) simultaneously to
[
15N]-labeled RBD1 (12.5nmol) resulted in two sets of
protein signals (Supplementary Figure S3). One set
overlapped the protein signals for the RBD1:numb6-2
complex and the other with those for the
RBD1:numb6-4 complex. The intensities of the signals
originating from the RBD1:numb6-2 and
RBD1:numb6-4 complexes were equivalent, suggesting
that the magnitudes of their dissociation constants are
comparable. Therefore, we chose r(GUAGU) as a
minimal RNA oligomer for use in further structural
studies.
Next, we have synthesized a 5-nt RNA oligomer
numb5, r(GUAGU), and performed NMR titration ex-
periments in order to determine whether or not this
sequence is of sufﬁcient length for structural determin-
ation. During the numb5 titration, many of the residues
of [
15N]-labeled RBD1 exhibited two distinct cross peaks
in
1H-
15N HSQC spectra, suggesting that numb5 binding
exhibits a slow exchange regime on the chemical shift
timescale. No free protein signals were observed when
the molar ratio reached RBD1:numb5=1:1, just like in
the cases when numb6-4 and numb6-2 were titrated
against RBD1. Almost all protein signals of the
RBD1:numb5 complex and those of the RBD1:numb6-2
and RBD1:numb6-4 complexes overlapped each other
(Figure 2A). In fact, the
1H and
15N chemical shift differ-
ences of [
15N]-labeled RBD1 in a complex with numb5
(Figure 2B) and those with either numb6-2 or numb6-4
turned out to be within the range of 0.05–0.3ppm, respect-
ively. Altogether, these data demonstrated that numb5
could be used for the further structural study to obtain
Nucleic Acids Research,2012, Vol.40, No. 7 3221important insights into the nature of the RNA binding by
Msi1 RBD1.
As for the RNA oligomers that bind to RBD2,
numb6-1, numb6-2 and numb6-4 exhibited a slow
exchange regime on the chemical shift timescale,
indicating that they exhibit stronger afﬁnity than the
other three. Each of the numb6-1, numb6-2 and
numb6-4 contains UAG and GUA sequences in
common, whereby they can be considered as candidates
for the Msi1 RBD2 recognition sequences. We further
ABC
DE F
GH I
J
M
KL
Figure 1. Binding of 6-nt RNA oligomers to individual RBDs of Msi1. Overlays of the
15N-HSQC spectra sections of RBD1 (red), and RBD1 in the
presence of 0.2 (orange), 0.5 (green), 1.0 (blue) and 1.2 (purple) equivalents of 6-nt RNA oligomers: (A) r(UAGGUA) (numb6-1); (B) r(GGUAGU)
(numb6-2); (C) r(UAGUAG) (numb6-3); (D) r(GUAGUU) (numb6-4); (E) r(AGUUUU) (numb6-5) and (F) r(GUUUUA) (numb6-6). Overlays of
the
15N-HSQC spectra sections of RBD2 (red) and RBD2 in the presence of 0.2 (orange), 0.5 (green), 1.0 (blue) and 1.2 (purple) equivalents of 6-nt
RNA oligomers: (G) numb6-1; (H) numb6-2; (I) numb6-3; (J) numb6-4; (K) numb6-5 and (L) numb6-6. (M) The chemical shift changes,  d, were
obtained by subtracting the chemical shifts of Msi1 backbone
1H
N for the free protein from the chemical shifts of Msi1 backbone
1H
N in the complex
(Msi1:RNA oligomer=1:1).
3222 Nucleic Acids Research, 2012,Vol.40, No. 7analyzed the amino acid residues of Msi1 RBD2 that are
involved in RNA binding, and their conservation with
those of Msi1 RBD1. As a result, we were able to deﬁne
UAG as the recognition sequence for Msi1 RBD2, with a
possible involvement of an arbitrary nucleotide in the
fourth position. The binding mode of Msi1 RBD2 and
UAG will be discussed in the ‘Discussion’ section.
Structure determination
In the previous section, we showed that Msi1 RBD1 binds
r(GUAGU)-containing RNA oligomers with high afﬁnity.
Here, we determined the solution structure of the complex
between Msi1 RBD1 (20–103) and Gua1-Ura2-Ade3-
Gua4-Ura5 (numb5) using the NMR method. We have
1716 intra-protein, 16 intra-RNA and 58 inter-molecular
protein–RNA upper distance limits. Intra-protein NOEs
were collected from
15N-edited NOESY-HSQC and
13C-edited NOESY-HSQC spectra. Intra-RNA NOEs
were obtained from
13C,
15N-[f1,f2]-ﬁltered NOESY
spectra, whereas
13C,
15N-[f2]-ﬁltered NOESY spectra
contained both intra-RNA and inter-molecular protein–
RNA NOEs. We were able to isolate just the
inter-molecular protein–RNA NOEs by careful compari-
son between these two sets of ﬁltered NOESY spectra.
Inter- and intra-molecular distance restraints were
derived from the intensities of the obtained NOEs.
Inspection of the J-coupling of H10–H20 cross-peaks in
the DQF-COSY spectra showed that the Gua1, Ura2,
Ade3 and Gua4 sugars adopt the C20-endo conformation
[JH10-H20  11Hz; (46)].
The structure calculation and reﬁnement were carried
out using program CYANA (51) and Amber9 (52).
Among the 200 independently calculated structures, the
40 conformers with the lowest CYANA target functions
were reﬁned by restrained energy minimization using solv-
ation simulation with program Amber9 (Table 2). The 20
conformers that were most consistent with the experimen-
tal restraints were selected as the ﬁnal structures
(Figure 3A and B).
Structure description of the Msi1 RBD1: numb5 complex
and the base-speciﬁc RNA recognition by Msi1 RBD1
The structure of Msi1 RBD1 in the complexed form
adopts a babbab topology: b1 (21–25), a1 (33–42), b2
(47–52), b3 (63–67), a2 (72–79) and b4 (91–94), with add-
itional short b-strands, sb (84–85, 88–89). These secondary
structure elements form a four-stranded anti-parallel
b-sheet, which is backed up by two a-helices on one
side. The additional short b-strands form a b-turn
located between a2 and b4. The overall protein structure
turned out to be identical to that in the RNA free state
(13). In the complex, r(GUAGU) (numb5) lies across the
four-stranded anti-parallel b-sheet, the 50-end of numb5
(Gua1) being located between two loops (loop b1-a1
and loop a2-b4), with the 30-end (Ura5) on b2
(Figure 3B). Four nucleotide residues, Gua1, Ura2,
A
B
Figure 2. r(GUAGU) (numb5) and r(GUAGUU) (numb6-4) bind equally well to RBD1 of Msi1. (A) Overlay of the
15N-HSQC spectra of RBD1
(red), RBD1 in the presence of a 1.0 equivalent of numb5 (cyan) and RBD1 in the presence of a 1.0 equivalent of numb6-4 (black). (B) The chemical
shift changes,  dH ( dN), were obtained by subtracting the chemical shifts of Msi1 backbone
1H
N (
15N) for the free protein from the chemical shifts
of Msi1 backbone
1H
N (
15N) in the complex.
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interaction with RBD1. These structural features will be
described in detail below.
The base of Gua1 stacks onto the indole ring of W29
and N7 of Gua1 seems to form a hydrogen bond with the
amide proton of W29 (Figure 3C). The latter is consistent
with the fact that the signal of the amide proton of W29
shows a large downﬁeld shift upon numb5 binding
(Figure 2B). The ring current effect of the nearby Gua1
base may also contribute to this large downﬁeld shift.
Additionally, Gua1 O6 and K88 Hz are located close
to each other, the distance between them being appropri-
ate for the formation of hydrogen bond. This is supported
by the inter-molecular NOEs between Gua1 H8 and K88
Hd. The backbone amide proton signals of S60 and R61
were upﬁeld shifted upon numb5 binding (Figure 2B).
This ring current effect of the indole of W29, which is
close to these amide protons, may be responsible for this
observation.
The structure of the complex indicated that Ura2 is
recognized through two hydrogen bonds: One between
O2 of the Ura2 base and K93 Hz, and the other
between the imino proton of the Ura2 base and D91 Od
(Figure 3D). These interactions result in the placement of
the ring of Ura2 proximal to the backbone amide proton
of G26 (Figure 3D). The structure obtained suggests the
upﬁeld shift of the G26 HN chemical shift can be induced
through the ring current of the Ura2 ring. Indeed, we
observed a 1.3ppm upﬁeld shift of the G26 HN
chemical shift as compared with the chemical shift of
G26 HN in the RBD1 free form (Figure 2B).
The base of Ade3 is sandwiched between the rings of
F23 (RNP2) and F96 (C-terminal region ﬂanking b4)
(Figure 3D and E). This structural feature is supported
by three inter-molecular NOEs: F96 HN-Ade3 H2, F96
He-Ade3 H8, and F96 Hd-Ade3 H3. No NOE was
observed between the F23 and F96 rings; this agrees
with the obtained structure as these rings are located on
opposite sides of Ade3. In addition, the structure suggests
two possible inter-molecular hydrogen bonds: one
between N1 of the Ade3 base and the backbone NH of
F96, and the other between Ade3 NH2 (or H6) and V94
CO (Figure 3E). The former is supported by the 1.4ppm
downﬁeld shift of F96 HN upon complex formation
(Figure 2B). Additionally, the strong NOE observed
between Ade3 H40 and F63 Hd He suggests that the
ribose ring of Ade3 is located near the F63 aromatic
ring (Figure 3D).
The base of Gua4 stacks onto the aromatic ring of F65,
which is one of the three conserved phenylalanines in
RNP1 (Figure 3E). Among the intra-residue NOEs
involving Gua4 H8, the NOE between H8 and sugar H10
exhibited the strongest intensity, whereas the intensities of
the NOEs between H8 and H20, H8 and H30, and H8 and
H50/H500 were either very weak or unobservable. This in-
dicates that Gua4 takes on the syn conformation around
the glycosidic bond (  angle). This conformation is also
supported by the observation of inter-molecular NOEs
between Gua4 H8 and the protons of RBD1 residues
such as M52 He, L50 Hd and F65 Hd/He/Hz; since the
inter-molecular distances between the corresponding
protons would be too great if the   angle was in the
anti-conformation. The structure also suggests that K21
Hz forms a hydrogen bond with Gua4 N7. This is mostly
due to the observed NOEs between K21 Hd and Hb and
Hd of F65, that is located just under Ade3 (Figure 3E).
Finally, inspection of the 20 ﬁnal structures of the Msi1
RBD1:numb5 complex showed that Ura5 is located near
b2 with poor convergence. This is due to the fact that no
intra- and inter-molecular NOEs involving Ura5 were
detected. Therefore, we concluded that Ura5 is not
actively recognized by Msi1 RBD1.
DISCUSSION
Features of the Msi1 RBD1:numb5 complex
First, in this study, we identiﬁed the minimal binding RNA
sequences for the individual RBD1 and RBD2 of Msi1.
Then, we determined the three-dimensional structure of
the Msi1 RBD1:r(GUAGU) (numb5) complex. The struc-
ture illustrated that Msi1 RBD1 lacks the interaction with
Ura5 at the 30-end; therefore, we concluded that Msi1
RBD1 requires just four bases, GUAG, for the recognition.
Msi1 RBD1 utilizes its b-sheet surface to bind GUAG, just
like most classical RBDs whose structures in the complex
state with a cognate RNA or DNA have been determined
(11). The structure of the Msi1 RBD1:numb5 complex
shares several attributes with most Ribonucleoprotein
(RNP)-type RBD:nucleic acids complexes, and some
features that are likely to be speciﬁc to the Msi1
RBD1:RNA complex. We will discuss the following
Table 2. Structural statistics for the Msi1 RBD1:numb5 complex
Restraints for ﬁnal structure calculations
Upper distance limits
Total 1790
Intra-protein 1716
short-range, ji jj 1 835
medium-range, 1<ji jj<5 281
long-range, j i j j 5 600
Intra-RNA 16
Inter-molecular 58
Number of dihedral angle restraints
  angles 4
Number of hydrogen bond restraints 0
Structure statistics (20 structures)
Number of NOE violations >0.2A ˚ 0
Number of dihedral angle violations >5  0
Average CYANA target function (A ˚ ): 0.18
Average AMBER energy (kcal·mol
 1):  4059.47
Average AMBER total restraint violation (kcal·mol
 1) 4.27
RMS deviation from the mean coordinate structure
Backbone heavy atoms (A ˚ )
Protein (21–97) 0.33±0.09
All heavy atoms (A ˚ )
Protein (21–97) 0.96±0.11
Protein (21–97) and RNA 0.94±0.11
Ramachandran statistics (%)
Residues in most favored regions 87.6
Residues in additional allowed regions 11.6
Residues in generously allowed regions 0.3
Residues in disallowed regions 0.5
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and numb5 that are shared by other RNP-type RBDs
and cognate RNAs, and then unique interactions that are
observed in the numb5 recognition by Msi1 RBD1.
In Msi1 RBD1, F23 of RNP2 (on b1) and F65 of RNP1
(on b3) are used to interact with Ade3 and Gua4, respect-
ively. These phenylalanines are conserved among many
RNP-type RBDs (10), such as those of hnRNP A1,
Figure 3. Structure of Msi1 RBD1 in a complex with r(GUAGU) (numb5). (A) Superpositioning of the 20 lowest energy conformers of the
RBD1:numb5 complex. The protein backbone (residues 20-103) is colored gray. RNA is shown as a stick model: hydrogen (pale gray), carbon
(green), nitrogen (blue), oxygen (red) and phosphorus (yellow). (B) The lowest energy conformer is presented and viewed from the same direction as
in (A). Protein side chains contributing to the RNA binding are shown as a stick model: hydrogen (pale gray), carbon (magenta), nitrogen (blue) and
oxygen (red); and aromatic rings are ﬁlled. RNA is represented as in (A). A schematic drawing of the RNA-binding b-sheet is presented at the
bottom. (C) Recognition of Gua1. The Gua1 base stacks onto the W29 indole ring; and hydrogen bonds, Gua1 N7-W29 HN and Gua1 O6- K88 Hz,
are formed. (D) Recognition of Ade3. The Ade3 base is sandwiched between the aromatic rings of F23 and F96; and hydrogen bonds, Ura2 N3-D91
Od, Ura2 O2-K93 Hz, Ade3 H6-V94 O and Ade3 N1-F96 HN, are formed. (E) Recognition of Gua4. The Gua4 base stacks onto the F65 aromatic
ring, and Gua4 N7 hydrogen bonds with K21 Hz. R61 HZ may form a salt bridge with the 50 phosphate group of Gua4. (F) The Ura2 base stacks in
the pocket. The solvent accessible surface of RBD1 is viewed from a similar direction to as in (D). D91, K93, F23 and F63 form a rim, and G25 and
G26 form the bottom of the pocket. Hydrogen bonds are indicated by dotted yellow lines. (B) and (D) are stereo diagrams.
Nucleic Acids Research,2012, Vol.40, No. 7 3225hnRNP D0 and Hrp1 (Figure 4). In all of these RBDs, the
base moiety of the nucleotide residues stacks onto the
aromatic ring of the conserved phenylalanines. Actually,
F18 of hnRNP A1, F162 of Hrp1 and F185 of hnRNP
D0, all of which correspond to F23 of Msi1, bind to
adenine of a cognate RNA (for hnRNP D0 and Hrp1)
or DNA (for hnRNP A1). In addition to this aromatic
stacking interaction between the adenine and phenylalan-
ine residues of RNP2, hydrogen bonds are formed
between Ade3 and amino acid residues on b4 (F96 HN-
Ade3 N1 in Msi1, R88 CO-Ade203 H6 in hnRNP A1 and
I234 HN-Ade6 N1 in Hrp1). In the case of the
Msi1:numb5 complex, the backbone amide proton of
F96 and the carbonyl oxygen of V94 are hydrogen
bonded to N1 and the amino group of Ade3. Similarly,
the amide protons of V90 in hnRNPA1, M258 in hnRNP
D0 and I234 in Hrp1 form hydrogen bonds with adenine
N1 of the cognate RNA; and R232 CO of Hrp1 forms a
hydrogen bond with adenine H6 of the cognate RNA.
The aromatic ring of F65 in Msi1 interacts with the base
of Gua4 by means of aromatic stacking. The equivalent
residues are F59 in hnRNP A1 and F227 in hnRNP D0,
both of which interact with guanine bases through
aromatic stacking. Interestingly, the corresponding
guanine in each of these complexes takes on the syn con-
formation as to the   angle. In addition, in all of these
complexes, the Gua4 base is hydrogen-bonded with the
side chains of amino acid residues on b1 (K21 in Msi1,
K15 in hnRNP A1 and K183 in hnRNP D0). K21 Hz (on
b1) in Msi1 approaches to N7 of the Gua4 base and forms
a hydrogen bond (Figure 4). Analogous hydrogen bonds
are formed in hnRNP A1 and hnRNP D0, each in the
complex form, where K15 and K183 correspond to K21
of Msi1, respectively (Figure 4). This lysine on b1 is ex-
clusively conserved among RBD1 and RBD2 of the Msi
family throughout different species (Supplementary
Figure S6). In some RBDs, such as Fox-1, the correspond-
ing amino acid residue is arginine (Figure 4), which can
also form a hydrogen bond with a guanine residue of a
cognate RNA (53). It seems that the basic amino acid
(lysine or arginine) on b1 at this position is important
for support and stabilization of the guanine–phenylalan-
ine aromatic stacking.
Inspection of the RBD1:r(GUAGU) complex structure
revealed that when Gua4 in the current syn conformation
is converted to anti, serious steric clashes are caused with
the surrounding amino acid residues. Steric clashes are
also caused when Gua4 is replaced by an adenosine in
the anti conformation. Thus, the syn conformation is
needed at the fourth position to avoid the steric clashes.
A guanosine can adopt the syn conformation more easily
than an adenosine. This could be a reason why a guano-
sine is preferred over an adenosine at the fourth position.
The inspection also revealed that an adenosine in the syn
conformation can be accommodated without a steric clash
in replacement of Gua4, although amino protons of the
adenosine are located close to the side chain of Lys21.
Thus, the steric hindrance involving amino protons of
an adenine alone does not account for the preference of
a guanosine at the fourth position. This also supports the
idea that a guanosine is preferred at the fourth position
due to its easiness to take on the syn conformation over an
adenosine.
Figure 3F shows a pocket on the molecular surface of
Msi1 RBD1 in which Ura2 ﬁts. This pocket comprises
D91, K93 and F23, forming a rim; and G25 and G26,
forming the bottom of the basin. All of these residues
are highly conserved in the Msi1 family (Figure 4). F23,
G25 and G26 are part of RNP2 (b1) and F63 is in RNP1
(b3). It is important that the residues at the positions of
G25 and G26 have no side chains. This requirement allows
the side chains of D91 and K93 on b4 to approach the
base of Ura2 from the horizontal direction and form
hydrogen bonds (Figure 3D). These charged amino acid
residues on the b4 are conserved in many RBDs
(Figure 4). For example, the residues at these positions
in RBD2 of hnRNP A1 and RBD1 of Hrp1 are aspartate
and lysine; and those in RBD1 of hnRNP A1 and RBD2
of hnRNP D0 are glutamate and lysine (Figure 4). The
pocket described above is also formed in these RBDs.
R61 of Msi1 RBD1, which is located at the N-terminus
of the RNP1 motif, reaches out to the phosphate
backbone of the nucleic acid sequence and undergoes an
electrostatic interaction (Figure 3D and Supplementary
Figure S3A). In many RNP-type RBDs whose structures
in complexes with cognate RNAs have been determined,
Figure 4. Amino acid sequence alignment of the RBDs of Msi family proteins and other proteins; Mus Musculus Msi1 RBD1 and RBD2,
M. Musculus Msi2 RBD1 and RBD2, Homo sapiens hnRNP A1 RBD1 (56), Saccharomyces cerevisiae Hrp1 RBD1 (54), H. sapiens Fox-1 (53),
H. sapiens hnRNP D0 RBD2 (57) and H. sapiens U2AF65 (58) are listed. The residues of Msi1 RBD1 that are suggested to interact with r(GUAGU)
(numb5), and the residues at the equivalent positions in the listed RBDs are highlighted in gray. W29 and F96 of Msi1 RBD1 are highly conserved in
the Msi family members (highlighted in black). The positions of the secondary structure elements (b, b-strand; a, a-helix; sb, short b-strands that
form a b-turn) determined for Msi1 RBD1 are shown at the bottom.
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lysine, all of which interact electrostatically with the phos-
phate backbone (Supplementary Figure S4A and C). So
far, we have discussed the interactions found in the Msi1
RBD1:numb5 complex that are commonly found in
complexes between other RNP-type RBDs and their
cognate nucleic acids.
Next, we will focus on the interactions that are unique
to the Msi1 RBD1:numb5 complex. The indole ring of
W29, which is located in the b1-a1 loop, and the purine
ring of Gua1 interact by means of aromatic stacking
(Figure 3C and Supplementary Figure S3B). First of all,
tryptophan is rarely found at this position in RNP-type
RBDs: 10% in 1200 RBDs (recorded in Pfam database on
February 2010). Hrp1, whose structure has been
determined in the complex state with its cognate RNA,
also has a tryptophan at the corresponding position
(54). However, Hrp1 uses this tryptophan to interact
with the base of an adenine by means of the aromatic
stacking (Supplementary Figure S4D). The difference in
base-recognition between Msi1 and Hrp1 originates from
the hydrogen bonds that support aromatic stacking in
each case. In the Msi1:numb5 complex, Gua1 N7 and
O6 are hydrogen-bonded with K88 Hz; while in the
Hrp1 and cognate RNA complex, Ade4 N7 and H6 are
hydrogen-bonded with W168 HN and N167 Od1, respect-
ively (Supplementary Figure S4D). The common architec-
ture for the purine ring recognition at the b1–a1 loop
between these two complexes is purine–indole aromatic
stacking, and the hydrogen bond between N7 of purine
and the amide of a tryptophan (Supplementary Figure
S3B and S3D). However, these two proteins recognize dif-
ferent purine rings, because the hydrogen bond networks
are different in these complexes.
Another unique feature found in the structure of the
Msi1 RBD1:numb5 complex is as follows. The interaction
between F23 of Msi1 RBD1 and Ade3 of numb5 has
already been described as typical aromatic stacking
among RNP-type RBDs. However, additional and appar-
ently speciﬁc interactions that involve Ade3 have also been
found. The aromatic ring of F96 stacks on top of the
purine base of Ade3, which is stacked on the aromatic
ring of F23 (Figure 3D). Thus, a F96-Ade3-F23
sandwich structure is formed. A similar sandwich struc-
ture was observed previously for the complex of an
atypical RBD and its target nucleic acid, which has a
rather specially modiﬁed base. CBP20, a component of
the nuclear cap-binding protein complex, sandwiches the
7-methylguanosine cap structure of the eukaryotic
50-terminus between two tyrosines, Y43 on the b-sheet
and Y20 in the N-terminal unstructured region (55). In
this case, however, the direction of the RNA bound to
the b-sheet surface was different to that of RNA bound
to common RNP-type RBDs including RBD of Msi1. In
the canonical mode of RNA binding, RNA crosses diag-
onally in the 50–30 direction on the b-sheet surface, in the
order of b1 (RNP1), b3 (RNP2) and b2 of RBD. On the
other hand, the cap structure, having a unique 50-50 con-
nection with the tri-phosphate bridge, lies in the opposite
direction on the b-sheet surface to CBP20. As far as we
know, this is the ﬁrst report that a sandwich structure
could be used for the recognition of a nucleic acid by a
typical RNP-type RBD.
Residues of RBD2 suggested to be involved in RNA
binding
RBD1 and RBD2 of mouse Msi1 exhibit high sequence
homology, the sequence identity and similarity being 45
and 65%, respectively. Our NMR titration experiments
have suggested that RBD2 recognizes either r(UAG) or
r(GUA). Among the residues of RBD1 that are involved
in RNA binding, K21, F23, R61, F63, F65, K88 and K93
are conserved in RBD2 (K110, F112, R150, F152, F154,
K177 and K182, respectively). Since all of these amino
acid residues, except for K88 are involved in binding to
the r(UAG) moiety in the RBD1:r(GUAGU) (numb5)
complex, it seems likely that RBD2 also uses the same
set of amino acid residues to bind the r(UAG). In fact,
experimental results on the chemical shift perturbation
support this. For example, in the case of RBD1, Ade3
stacks onto F23 (Figure 3D) and accordingly, the follow-
ing residue, I24, exhibits large negative chemical shift per-
turbation due to the ring current effect (Figure 2B). The
residue of RBD2 that corresponds to F23 of RBD1 is
F112 (Figure 4). Therefore, stacking of Ade3 onto F112
is expected. Large negative chemical shift perturbation
observed for V113 that follows F112 (Supplementary
Figure S5) supports this expected stacking. Thus, it is
strongly suggested that RBD2 uses the same set of
amino acid residues as RBD1 for binding and that the
recognition sequence of RBD2 is r(UAG).
The residues that are not conserved in these two
domains but are involved in RNA binding in RBD1 are
W29 (Gua1 binding), D91 (Ura2 binding) and F96 (Ade3
binding), which are substituted by valine, glutamate and
glutamine in RBD2, respectively. Among them, as
described in the text, W29 of Msi1 RBD1 is important
for the stacking interaction with the ﬁrst guanine, Gua1,
of r(GUAGU) (numb5). The corresponding residue in
Msi1 RBD2 is V118, which cannot undergo a stacking
interaction due to its chemical structure, thus V118
seems not to interact with Gua1. This is supported by
the experimental result that V118, N119 and T120 of
RBD2 exhibited much smaller chemical shift perturbation
than the corresponding W29, Q30 and T31 of RBD1,
upon addition of any of the RNA oligomers used in this
study (Figure 2B and Supplementary Figure S5). Thus,
Gua1 of r(GUAGU) is not recognized by RBD2. This
reveals that the recognition sequence of RBD2 is not
r(GUA). Thus, we can conclude that the recognition
sequence of RBD2 is r(UAG).
E180 of RBD2, which corresponds to D91 in RBD1,
probably interacts with uracil (Ura2) in the same manner.
F96 of RBD1 stacks onto Ade3, which is stacked onto
F23, to form an F23–Ade3–F96 sandwich. It is not
likely that Q185 of RBD2, which corresponds to F96 of
RBD1, undergoes a similar stacking interaction, although
the possibility of a stacking interaction cannot be excluded
completely because of the sp2 feature of the glutamine side
chain. Msi1 RBD2 reportedly exhibits lower RNA-
binding afﬁnity than RBD1 (13). We assume that this
Nucleic Acids Research,2012, Vol.40, No. 7 3227lower binding afﬁnity is due to the lack of tryptophan–
guanine stacking and/or phenylalanine–adenine–phenyl-
alanine sandwich stacking interactions. In summary,
RBD2 recognizes three nucleotides, r(UAG), with a pos-
sibility of involvement of an arbitrary nucleotide in the
fourth position.
Our chemical shift perturbation experiments showed
that the binding between Msi1 RBD2 and numb6-
3exhibits an intermediate exchange regime on the NMR
timescale. Since numb6-3 has two sequential r(UAG) se-
quences, this phenomena can be explained by the multiple
registration of Msi1 RBD2 for numb6-3 binding.
The possible target RNAs of Msi1 possessing r(GUAG)
and r(UAG)
The target RNA of Drosophila Msi and mouse Msi1 was
originally identiﬁed as r(GUU...UAG)n or
r(GUU...UG)n (n=2, 3) and (G/A)UnAGU (n=1–3),
respectively by means of in vitro selection, SELEX (14,59).
From this information, Drosophila ttk69 and mouse numb,
each of which encodes an important factor that plays
a key role in the differentiation regulation of neural
stem cells, were identiﬁed (14,59). In the present study,
we used NMR spectroscopy to deﬁne the minimal
RNA-binding sequences of mouse Msi1 RBDs. It
was found that r(GUAG) and r(UAG) are the minimal
recognition sequences for Msi1 RBD1 and RBD2,
respectively.
Here, we have reanalyzed the sequence of Drosophila
ttk69 mRNA, and searched for r(GUAG) and r(UAG).
It turned out that there are several sequence stretches that
contain these minimal recognition sequences connected by
variable linker regions (2–4nt) (Supplementary Figure
S6). We also compared the amino acid sequences of the
Msi proteins from different species (Supplementary Figure
S6). It turned out that mouse Msi1 and Drosophila Msi
exhibit high sequence homology: 55% identity and 73%
similarity for RBDs; and that the residues of Msi1 RBDs
that participate in the RNA binding are highly conserved
in Drosophila Msi (Supplementary Figure S6). These
results imply that Drosophila Msi and mouse Msi1 recog-
nize their target RNA sequences in a similar, if not the
same, manner.
Next, we searched for the minimal recognition
sequences, r(GUAG) and r(UAG), in the 30-UTR of
numb mRNAs originating from other vertebrate species.
Again, we were able to ﬁnd these minimal recognition
sequences located within 3–4nt. The Supplementary
Figure S6 demonstrates that all the residues of Msi1
RBDs that participate in the binding of the minimal rec-
ognition sequences are conserved in Msi1 from other ver-
tebrates. These results strongly suggest that the molecular
mechanisms by which the Msi proteins regulate transla-
tion of numb mRNAs are conserved widely among
vertebrates.
Many vertebrate mRNAs reportedly contain Msi1
binding sites in their 30-UTRs (17,26). Next, we searched
for r(GUAG) and r(UAG) within these 30-UTRs. Indeed,
we were able to list the portions of the 30-UTRs that
contain these minimal recognition sequences (Figure 5).
r(GUAG) and r(UAG) turned out to be connected via
variable linkers (1–50nt long).
Thus, the present study has revealed that r(GUAG) and
r(UAG) are the minimal recognition sequences for Msi
proteins and are extensively conserved within the target
mRNAs of Msi proteins.
Biological implications for RNA recognition by the Msi
family
In mammals, two members of the Msi family, not only
Msi1, but also Msi2 are co-expressed in neural precursor
cells, including central nervous system (CNS) stem cells.
Neurosphere formation is reportedly inhibited when the
Msi1 and Msi2 genes are knocked out simultaneously,
however, single knockout does not bring about such dis-
turbance (60). Two recent reports identiﬁed Msi2 as a key
Figure 5. A list of 30-UTR regions of the putative Msi1 targets; H. sapiens numb (accession code NM_001005744.1), H. sapiens p21
WAF-1
(NM_078467.1), M. musculus dcx (NM_001110223.1), H. sapiens BKG3 (NM_006806.4), H. sapiens CCNG2 (NM_004354.2), H. sapiens CDK2A
(NM_001195132.1), H. sapiens DEPDC1 (NM_001114120.1), H. sapiens ERH (NM_004450.2), H. sapiens KIAA0101 (NM_001029909.1), H. sapiens
PTBP2 (NM_021190.2), H. sapiens RCN2 (NM_002902.2), H. sapiens RNF11 (NM_014372.4), H. sapiens STMN1 (NM_001145454.1), H. sapiens
TMCO1 (NM_019026.3), H. sapiens TSPAN3 (NM_001168412.1) and H. sapiens WUAP (NM_004906.3). Binding sequences for Msi1 RBD1
(GUAG) and RBD2 (UAG) are highlighted in black and gray, respectively.
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phase to the blast crisis phase (34,35). According to
these reports, Numb is downregulated in blast crisis
CML and exogenous expression of Numb inhibits leu-
kemogenesis. Consequently, upregulated Msi2 in blast
crisis CML negatively regulates the expression of Numb.
High expression of Msi2 was also found in leukemic cells
of acute myelogenous leukemia (AML) patients, and
elevated Msi2 expression was shown to be associated
with a poor prognosis in both AML and CML.
Exogenous expression of Msi2 enhanced the development
of aggressive immature leukemia induced by BCR-ABL.
These reports emphasize the importance of the
Msi2-Numb pathway in regulating the development of ag-
gressive myeloid leukemia.
Next, we examined if the present study could provide
information on the RNA recognition by Msi2. We
compared the amino acid sequences of Msi2 and Msi1.
The RBD1–2 regions of Msi1 and Msi2 of both mouse
and human exhibit high sequence homology: 85% identity
and 91% similarity. The residues that are important for
Msi1 RBD1 to recognize r(GUAG) turned out to be com-
pletely conserved in Msi2 RBD1 (Figure 4). As described
in the previous section, we also identiﬁed the residues of
Msi1 RBD2 that are possibly involved in r(UAG) recog-
nition. These residues are also fully conserved in Msi2
RBD2 (Figure 4). These ﬁndings suggest that Msi1 and
Msi2 may recognize the same RNA sequences, which
explains the results of double knockout experiments re-
garding the neurosphere formation. Consequently, it is
tempting to assume that Msi1 and Msi2 target for the
same mRNAs and play crucial roles in controlling
self-renewal, proliferation and leukemogenesis by either
suppressing (2,34,35) or promoting (16) translation. Our
next questions would be: what are the functions of Msi1
and Msi2, and how are they regulated? Although the
RBD1–2 regions of Msi1 and Msi2 are highly conserved,
the C-terminal regions of these two proteins are quite dif-
ferent in length and amino acid sequence: 56% identity
and 63% similarity. We therefore hypothesize that their
C-terminal regions may play important roles in protein–
protein interactions and/or autoregulation. Indeed, Msi1
has a putative PABP binding site following RBD2 (9).
This region is not conserved in Msi1 and Msi2. It is also
possible that Msi1 and Msi2 are regulated by post-
translational modiﬁcations. Future biological and struc-
tural studies on Msi1 and Msi2 will facilitate not only
understanding of the functions of Msi family proteins
but also reveal therapeutic strategies against aggressive
forms of myeloid leukemia.
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